LPTX vs CSBR
Comparison between Leap Therapeutics Inc (LPTX, Company) and Champions Oncology Inc (CSBR, Company).
Both LPTX and CSBR are from the Healthcare sector.
5-Year PerformanceCSBR has outperformed LPTX, delivering a return of -10.5% compared to -33.2%
LPTX vs CSBR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LPTX vs CSBR - Historical Returns
Returns include dividend reinvestment.
LPTX vs CSBR - Annual Returns (2007 - 2026)
Returns include dividend reinvestment.
| Year | LPTX | CSBR |
|---|---|---|
| 2026 | N/A | -9.91% |
| 2025 | -36.34% | -15.73% |
| 2024 | -38.44% | +48.01% |
| 2023 | -3.60% | +27.15% |
| 2022 | -86.57% | -46.82% |
| 2021 | +48.62% | -22.59% |
| 2020 | +112.26% | +32.56% |
| 2019 | -54.10% | +5.58% |
| 2018 | -67.79% | +94.28% |
| 2017 | -20.61% | +36.14% |
| 2016 | N/A | -33.07% |
| 2015 | N/A | -40.50% |
| 2014 | N/A | -58.33% |
| 2013 | N/A | +300.00% |
| 2012 | N/A | -60.00% |
| 2011 | N/A | -16.67% |
| 2010 | N/A | +12.50% |
| 2009 | N/A | -25.93% |
| 2008 | N/A | -20.00% |
| 2007 | N/A | +133.33% |
LPTX vs CSBR Drawdown Comparison
The maximum drawdown for LPTX was -99.76%, occurring on Aug 14, 2025. This drawdown has not yet recovered.
The maximum drawdown for CSBR was -94.13%, occurring on Sep 16, 2016. This drawdown has not yet recovered.
The current LPTX drawdown is -97.95%. The current CSBR drawdown is -76.19%.
| Rank | LPTX | CSBR |
|---|---|---|
| #1 | -99.76% Apr 12, 2018 - Aug 14, 2025 | -94.13% Oct 24, 2007 - Sep 16, 2016 |
| #2 | -46.34% Mar 8, 2017 - Apr 5, 2018 | -58.33% Feb 2, 2007 - May 31, 2007 |
| #3 | -28.81% Jan 26, 2017 - Mar 7, 2017 | -35.71% Jun 1, 2007 - Oct 10, 2007 |
| #4 | -9.00% Apr 5, 2018 - Apr 12, 2018 | -12.71% Oct 18, 2007 - Oct 23, 2007 |
Correlation
Correlation between LPTX and CSBR is -0.19 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks